Public Alert No: 039/2026 – Alert on the Risk of Drug Poisoning Associated with Concurrent Use of Gabapentinoids and Other Medicines
The National Agency for Food and Drug Administration and Control (NAFDAC) is informing healthcare professionals and the public of a report received concerning emerging evidence showing an increased risk of drug poisoning when gabapentinoids (gabapentin and pregabalin) are used together with certain medicines, particularly opioids and benzodiazepines. A study conducted by researchers at University College […]
Public Alert No. 038/2026 – Alert on Adulterated and Substandard Medicines- NITRAS, KADIN 2, ACEFYL and LORATADINE 24 Recalled by the Drug Regulatory Authority of Pakistan (DRAP)
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare professionals, importers, distributors, retailers, and the public that the Drug Regulatory Authority of Pakistan (DRAP) has recalled specific batches of adulterated and substandard medicines (Nitras, Kadin 2, Acefyl and Loratadine 24) due to quality defects, contamination concerns, and failure to meet […]
